-
Mashup Score: 7Overcoming Hormone Therapy Resistance in Prostate Cancer with Sarki Abdulkadir, MD, PhD - 2 month(s) ago
The MYC oncogene is notorious in the cancer research world because it is implicated in many advanced or aggressive cancers such as treatment-resistant prostate cancer. In this episode, Sarki Abdulkadir, MD, PhD, shares how his team bucked the conventional notion that the MYC gene is “undruggable” and uncovered a handful of compounds that block MYC gene activity, making prostate cancer tumors sensitive to hormone therapy and opening up a potential new therapeutic target for treatment-resistant prostate cancer.
Source: www.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5Overcoming Hormone Therapy Resistance in Prostate Cancer with Sarki Abdulkadir, MD, PhD - 2 month(s) ago
The MYC oncogene is notorious in the cancer research world because it is implicated in many advanced or aggressive cancers such as treatment-resistant prostate cancer. In this episode, Sarki Abdulkadir, MD, PhD, shares how his team bucked the conventional notion that the MYC gene is “undruggable” and uncovered a handful of compounds that block MYC gene activity, making prostate cancer tumors sensitive to hormone therapy and opening up a potential new therapeutic target for treatment-resistant prostate cancer.
Source: www.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
In this #BreakthroughsPodcast, @SarkiAbdulkadi1 discusses overcoming hormone therapy resistance in prostate cancer, why an open mind in cancer research makes progress possible, and his goals as Co-PI of Lurie Cancer Center’s #ProstateCancer SPORE: https://t.co/vizUD7FSEA #PCSM https://t.co/mkHCVghL2N
-
-
Mashup Score: 0Kenneth R Carson: Faculty Profiles: Feinberg School of Medicine - 2 month(s) ago
Read the Northwestern University Feinberg School of Medicine Faculty Profile of Kenneth R Carson
Source: www.feinberg.northwestern.eduCategories: General Medicine News, Hem/OncsTweet-
@AaronGoodman33 Ken Carson is an old friend and NW lymphoma doc. I don’t have a current email but reached out to try to get it… https://t.co/zhJECuE8YA
-
-
Mashup Score: 3
For decades, Marcus Peter, PhD, has drilled into an area of research focused on cell death and the roles of toxic and protective short RNAs, with the goal of developing a novel form of cancer treatment. Now, this same line of research has led Peter’s team to uncover new insights into the cause of Alzheimer’s disease. In this episode, Peter explains his pioneering work in investigating RNA interference in diseases and explains how his lab’s latest novel discovery may have relevance to an array of neurodegenerative diseases beyond Alzheimer’s.
Source: www.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
In this #Breakthroughs podcast, Marcus Peter, PhD, explains how pioneering #cancerresearch in his lab at @LurieCancer led to new insights into Alzheimer’s disease. https://t.co/rRN85OaUO6 https://t.co/Sm06dug9Ef
-
-
Mashup Score: 23A Compelling New Lupus Discovery with Jaehyuk Choi, MD, PhD - 4 month(s) ago
Northwestern Medicine physician-scientist Jaehyuk Choi, MD, PhD joins the show again to discuss another breakthrough in T-cell research. This time for lupus, a chronic autoimmune condition affecting 300,000 Americans that can cause inflammation in many body parts, including joints, skin, kidneys, blood cells, brain, heart and lungs. Findings by Choi and his lab members not only elucidate the underlying mechanisms of lupus but also suggest potential therapeutic strategies.
Source: www.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
A compelling new discovery in T-cell research from @LurieCancer member @jaehyukchoimd identified a cause for lupus and a possible way to reverse it, per findings in @Nature. Hear more about his innovative approach in this #BreakthroughsPodcast: https://t.co/77cwKnVsCB… https://t.co/duhIeot2Ja https://t.co/S5Lr2sEfjt
-
-
Mashup Score: 18How Mitochondria Inform Disease Discoveries with Navdeep Chandel, PhD - 11 month(s) ago
Mitochondria are widely known as cellular “powerhouses” for their role in producing energy for cells. But pioneering research from Northwestern Medicine investigators over the last 20 years has proven mitochondria are also major players in lung disease, cancer, brain disease and immune-related diseases. Navdeep Chandel, PhD, a 2023 recipient of the Lurie Prize in Biomedical Sciences by the Foundation for the National Institutes of Health, leads this research. In this episode he discusses how his team’s recent findings could advance the design and implementation of new therapies.
Source: www.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet-
Listen to this “Breakthroughs” podcast to hear from Lurie Cancer Center’s Navdeep Chandel, PhD, about how his team’s recent findings could advance the design and implementation of new cancer therapies. https://t.co/mjIwHS25t2 via @NUFeinbergMed #mitochondria
-
-
Mashup Score: 7Northwestern News - 1 year(s) ago
The basic science academic departments welcome members of the Northwestern community to attend upcoming seminars. Please click on the event times for more details, updates and to confirm the event format (in-person, hybrid or virtual). Campus partner events are noted below with an asterisk. Charles Burant, MD, PhD Dr. Robert C. and Veronica Atkins Professor of Metabolism Professor of Internal Medicine, Molecular and Integrative Physiology, and of Nutritional Sciences Director, A. Alfred Taubman Medical
Source: www.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
RT @NU_BSA: 🔬🧪Mark your calendars with a new lineup of basic science events.📆 Stayed updated and learn more here: https://t.co/YTKmS9i518…
-
-
Mashup Score: 1Improving Exercise Habits for Breast Cancer Survivors with Siobhan Phillips, PhD, MPH - 2 year(s) ago
There’s strong evidence that physical activity can play an important role in the health and lifespan of cancer survivors. Siobhan Phillips, PhD, MPH, leads the Exercise and Health Lab at Feinberg, which designs, tests, implements and disseminates physical activity interventions to support cancer survivors.
Source: www.feinberg.northwestern.eduCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“A lot of people do this ‘all or nothing attitude.’” Lurie Cancer Center’s Siobhan Phillips, PhD, discusses wearable technology and increasing physical activity for #breastcancer survivors in this #Breakthroughs podcast: https://t.co/24yLg7NQSW @smphillips19
-
-
Mashup Score: 0Northwestern University Nervous System Tumor Bank - 2 year(s) ago
The Northwestern University Nervous System Tumor Bank provides scientists with high-quality, patient-derived biospecimens to support preclinical and translational neuro-oncology research.
Source: www.feinberg.northwestern.eduCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
If you missed @KatyMccortney’s workshop @ISBER_ORG, learn how our Nervous System Tumor Bank at @NUFeinbergMed supports neuro-oncology research at: https://t.co/j7SEgndGJt #btsm https://t.co/E0ltCm4A9g
-
-
Mashup Score: 0Advancing Skin Cell Biology with Kathleen Green, PhD - 2 year(s) ago
Skin diseases from psoriasis to melanoma affect as many as one in three Americans at any given time. Kathleen Green, PhD, has greatly advanced basic molecular research related to skin diseases. She discusses recent discoveries in her lab that could lead to future therapeutic targets.
Source: www.feinberg.northwestern.eduCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Kathleen Green, PhD, (@kjgreen47) Associate Director of Basic Sciences Research @LurieCancer, discusses discoveries in her lab that may lead to new therapeutic targets & #BetterCancerCare. Listen to the #BreakthroughsPodcast https://t.co/iyrG5Ho4Ap @NUFeinbergMed @KathyGreenLab… https://t.co/w9IEIESWoZ
-
In this #BreakthroughsPodcast, @SarkiAbdulkadi1 discusses overcoming hormone therapy resistance in prostate cancer, why an open mind in cancer research makes progress possible, and his goals as Co-PI of Lurie Cancer Center’s #ProstateCancer SPORE: https://t.co/vizUD7FSEA #PCSM https://t.co/mkHCVghL2N